LRRK2

Parkinson’s Awareness Month

April 18, 2017
April is Parkinson’s Awareness Month and this year it also marks the eighth anniversary of 23andMe’s Parkinson’s Research Community, which introduced a game-changing model for science, one that leverages online...
Read More

What’s New In Parkinson’s Research

November 18, 2015
The panel discussing Parkinson’s Progression Marker Initiative at the MJFF’s Parkinson’s Disease Therapeutics Conference in New York. From implanting cells into the brain to prevent the loss of dopamine producing...
Read More

A New Model for Discerning Parkinson’s

August 13, 2015
A team of researchers has developed a simple and non-invasive approach that uses genetic data in combination with other demographic and biomarker information to accurately distinguish those with and without...
Read More

An Interview With Paul Cannon

March 30, 2015
We’re re-posting an interview that the Michael J. Fox Foundation did with our very own Paul Cannon, PhD, 23andMe’s Parkinson’s Research Community manager. April is Parkinson’s Awareness Month and this...
Read More

Debate Around Informing Research Participants

May 22, 2014
This post comes to us from our friends at the Michael J. Fox Foundation, which has worked with us through our Parkinson’s Research Community. There are many different points of...
Read More

Whole-Genome Sequencing of Parkinson’s Patients

November 05, 2012
(Editor’s note: Here is a link to Cory’s poster presented at ASHG.) Parkinson’s disease (PD) research has long been a priority at 23andMe. Our Parkinson’s research community is one of...
Read More

Highlighting 23andMe Research

July 29, 2012
Team 23andMe will again have a strong presence at the annual meeting of the American Society of Human Genetics. We’ve been at this gathering of geneticists and those interested in...
Read More

23andMe’s Parkinson’s Community is Almost There

July 17, 2012
23andMe’s Emily Drabant, PhD, speaking at a Parkinson’s event in Iowa. 23andMe is tantalizingly close to reaching the goal of enrolling 10,000 patients in our Parkinson’s research community. We’re past...
Read More

Announcing 23andMe’s First Patent

May 28, 2012
23andMe has a substantial research arm with more than 20 scientists dedicated to making meaningful discoveries that will improve the lives of all of us. We do not want our discoveries to just be an academic pursuit -- we want to meaningfully improve lives. Our first patent is an important step in ensuring that we’ve done all we can towards successful translation of a promising discovery in Parkinson's disease.
Read More

23andMe Parkinson’s Research Initiative Progress Update

January 26, 2010
By Nick Eriksson, 23andMe Principal Scientist, and Lizzie Dorfman, Parkinson’s Research Project Manager Less than a year ago we announced the launch of the 23andMe Parkinson’s Research Initiative. Since then,...
Read More